Pharming (PHAR) Receivables - Other (2019 - 2025)
Pharming's (PHAR) quarterly Receivables - Other came in at $1.9 million in Q4 2025, up 21.05% YoY from $1.6 million in Q4 2024, and up 21.05% on a QoQ basis from $1.6 million in Q4 2024.
Pharming (PHAR) Receivables - Other (2019 - 2025) Analysis & Trends
Pharming (PHAR) has 6 years of Receivables - Other data on file, last reported at $1.9 million in Q4 2025.
- Quarterly Receivables - Other rose 21.05% year-over-year to $1.9 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $1.9 million (up 21.05% YoY) and the FY2025 annual result came in at $1.9 million, up 21.05% from the prior year.
- Receivables - Other rose to $1.9 million in Q4 2025, from $1.6 million in the prior quarter.
- In the past five years, Receivables - Other ranged from a high of $2.1 million in Q4 2023 to a low of $1.1 million in Q4 2022.
- A 4-year average of $1.7 million and a median of $1.8 million in 2024 frame the typical range for Receivables - Other.
- Annual changes were most pronounced in 2023 — Receivables - Other soared 92.03% — and 2024, when it fell 25.59%.
- Tracing PHAR's Receivables - Other over 4 years: stood at $1.1 million in 2022, then soared by 92.03% to $2.1 million in 2023, then retreated by 25.59% to $1.6 million in 2024, then grew by 21.05% to $1.9 million in 2025.
- The last three Receivables - Other figures came in at $1.9 million (Q4 2025), $1.6 million (Q4 2024), and $2.1 million (Q4 2023), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Pharming | 824.47 Mn | 666.19 Mn | 141.47 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 1.93 Mn |
| Dec 31, 2025 | 1.93 Mn |
| Dec 31, 2024 | 1.60 Mn |
| Dec 31, 2024 | 1.60 Mn |
| Dec 31, 2023 | 2.15 Mn |
| Dec 31, 2023 | 2.15 Mn |
| Dec 31, 2022 | 1.12 Mn |
| Dec 31, 2022 | 1.12 Mn |
| Dec 31, 2020 | 2.24 Mn |
| Dec 31, 2020 | 2.24 Mn |
| Dec 31, 2019 | 854,517.28 |
| Dec 31, 2019 | 854,517.28 |